Fumitaka Ohsuzu Selected Research

Fumitaka Ohsuzu Research Topics

Disease

25	Coronary Artery Disease (Coronary Atherosclerosis) 01/2011 - 01/2002
19	Atherosclerosis 06/2012 - 01/2003
13	Inflammation (Inflammations) 01/2012 - 07/2002
7	Atherosclerotic Plaque (Atheroma) 03/2010 - 06/2002
5	Cardiovascular Diseases (Cardiovascular Disease) 03/2013 - 08/2003
5	Hyperplasia 02/2012 - 01/2002
4	Vascular Diseases (Vascular Disease) 01/2007 - 01/2004
3	Ischemia 07/2013 - 01/2002
3	Unstable Angina 01/2011 - 03/2009
3	Aortic Dissection 11/2009 - 10/2003
3	Myocardial Ischemia (Ischemic Heart Diseases) 04/2006 - 01/2002
3	Infections 05/2005 - 01/2004
2	Dyslipidemias (Dyslipidemia) 03/2013 - 09/2007
2	Vascular System Injuries 02/2012 - 01/2011
2	Thrombosis (Thrombus) 10/2011 - 04/2004
2	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 07/2006 - 12/2003
2	Hypertrophy 07/2006 - 12/2003
2	Rheumatoid Arthritis 08/2005 - 06/2003
2	Insulin Resistance 07/2005 - 01/2003
2	Hyperemia 11/2004 - 01/2002
2	Sleep Deprivation 10/2004 - 04/2004
2	Pathologic Constriction (Stenosis) 05/2004 - 01/2002
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 02/2004 - 01/2002
2	Syncope (Fainting) 07/2003 - 11/2002
1	Reperfusion Injury 07/2013
1	Hypoxia (Hypoxemia) 07/2012
1	Aneurysm (Aneurysms) 03/2012
1	Arteritis 01/2012
1	Stroke (Strokes) 01/2011
1	Ventricular Tachycardia 06/2010
1	Brugada Syndrome 06/2010
1	Ventricular Fibrillation 06/2010
1	Aortic Valve Disease 04/2010
1	Aortic Valve Stenosis (Aortic Stenosis) 04/2010

Drug/Important Bio-Agent (IBA)

7	CholesterolIBA 01/2012 - 02/2003
7	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 04/2010 - 08/2003
6	oxidized low density lipoproteinIBA 01/2012 - 06/2002
5	OsteopontinIBA 06/2010 - 10/2003
5	InterleukinsIBA 07/2006 - 08/2003
4	Messenger RNA (mRNA)IBA 07/2012 - 10/2003
4	C-Reactive ProteinIBA 05/2010 - 01/2005
4	ElastinIBA 11/2009 - 06/2002
4	Acetylcholine (Acetylcholine Chloride)FDA Link 11/2006 - 03/2005
4	Vasodilator Agents (Vasodilators)IBA 11/2006 - 01/2002
4	CytokinesIBA 07/2006 - 08/2003
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 03/2013 - 01/2005
3	Proteins (Proteins, Gene)FDA Link 07/2012 - 11/2009
3	Deficiency of interleukin-1 receptor antagonistIBA 03/2012 - 02/2005
3	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 01/2012 - 01/2004
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2010 - 07/2002
3	Matrix Metalloproteinases (MMPs)IBA 03/2010 - 09/2005
3	LipidsIBA 11/2009 - 06/2002
3	CollagenIBA 01/2007 - 06/2002
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2007 - 10/2002
3	EnzymesIBA 02/2004 - 01/2003
2	UbiquitinIBA 07/2012 - 09/2011
2	Proteasome Endopeptidase Complex (Proteasome)IBA 07/2012 - 09/2011
2	HDL CholesterolIBA 06/2012 - 01/2008
2	Interleukin-6 (Interleukin 6)IBA 02/2012 - 08/2005
2	ResistinIBA 01/2011 - 07/2005
2	Matrix Metalloproteinase 8 (Neutrophil Collagenase)IBA 03/2010 - 09/2005
2	GadoliniumIBA 03/2009 - 01/2004
2	AnionsIBA 03/2009 - 07/2006
2	Radioisotopes (Radionuclides)IBA 08/2007 - 11/2002
2	Interleukin-1 (Interleukin 1)IBA 07/2006 - 07/2006
2	CatecholaminesIBA 10/2004 - 07/2003
2	nipradilolIBA 10/2004 - 01/2002
2	MagnesiumIBA 10/2004 - 04/2004
2	Norepinephrine (Noradrenaline)FDA LinkGeneric 10/2004 - 07/2003
2	ImmunosorbentsIBA 02/2004 - 10/2003
2	Antinuclear AntibodiesIBA 02/2004 - 01/2002
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 07/2013
1	3-aminobenzamideIBA 07/2013
1	Pravastatin (Pravachol)FDA LinkGeneric 03/2013
1	Transcription Factors (Transcription Factor)IBA 07/2012
1	Fluvastatin FDA Link 07/2012
1	Endothelin-1 (Endothelin 1)IBA 07/2012
1	LDL CholesterolIBA 06/2012
1	Lipoprotein(a)IBA 05/2012
1	Immunoglobulin G (IgG)IBA 02/2012
1	Biomarkers (Surrogate Marker)IBA 02/2012
1	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 02/2012
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 01/2012
1	Type I Tumor Necrosis Factor ReceptorsIBA 01/2012
1	ChemokinesIBA 01/2012
1	NG-Nitroarginine Methyl Ester (L-NAME)IBA 11/2011
1	arginine methyl esterIBA 11/2011
1	Hemoglobins (Hemoglobin)IBA 11/2011
1	Contrast MediaIBA 10/2011
1	Platelet Membrane GlycoproteinsIBA 10/2011
1	FluorocarbonsIBA 10/2011
1	arginyl-glycyl-aspartic acidIBA 10/2011
1	omega-Chloroacetophenone (Mace)IBA 01/2011
1	AdipokinesIBA 01/2011
1	Superoxide DismutaseIBA 01/2011
1	pilsicainideIBA 06/2010
1	Coffee FDA Link 03/2010

Therapy/Procedure

8	Therapeutics 03/2013 - 01/2002
2	Percutaneous Coronary Intervention 01/2011 - 02/2009
2	Stents 01/2011 - 01/2002